Tagrisso OverviewOsimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. The most common side effects include diarrhea, rash, musculoskeletal pain, dry skin, skin inflammation around nails, sore mouth, fatigue and cough. Osimertinib was approved for medical use in the Unit...
Read more Tagrisso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Osimertinib
Recent Tagrisso Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 40mg, 80mg
NDC Database Records for Tagrisso: (2 results)Sorted by National Drug Code
- 0310-1349 Tagrisso 40 1/1 Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-1350 Tagrisso 80 1/1 Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp